Therese Bartholomew Bevers MD, FAAFP

Therese B. Bevers, MD, is professor of Clinical Cancer Prevention and the medical director of the Cancer Prevention Center and prevention outreach programs at MD Anderson Cancer Center.In her role as medical director, Dr. Bevers has overseen the growth and program development of the Cancer Prevention Center—the first comprehensive clinical cancer prevention service program in the country—since its opening in 1996.

Her clinical and research interests are in the area of breast cancer prevention, screening and diagnosis. She was the MD Anderson co-principal investigator (PI) on the groundbreaking Breast Cancer Prevention Trial which demonstrated that tamoxifen reduced the risk of developing breast cancer by one half and PI of the STAR trial which showed that raloxifene had similar benefits but fewer risks.

She was the PI at MD Anderson for a study investigating whether polyphenon E, an active substance of green tea, benefits women at increased risk for breast cancer. She is also investigating the potential role of Vitamin D in breast cancer prevention. Dr. Bevers chairs the National Comprehensive Cancer Network’s guideline panels on Breast Cancer Screening and Diagnosis and Breast Cancer Risk Reduction.

She is the recipient of many awards including the Julie and Ben Rogers Award for Excellence in Prevention in 2006, the Kathryn S. Stream Award for Excellence in Women’s Health in 2011 and the Faculty Achievement Award in Prevention in 2011.